{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T20:00:24Z","timestamp":1781294424730,"version":"3.54.1"},"reference-count":72,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.neuroscience.2009.03.083","type":"journal-article","created":{"date-parts":[[2009,4,10]],"date-time":"2009-04-10T08:22:22Z","timestamp":1239351742000},"page":"940-949","source":"Crossref","is-referenced-by-count":33,"title":["In vivo dopamine release and uptake impairments in rats treated with 3-nitropropionic acid"],"prefix":"10.1016","volume":"161","author":[{"given":"J.C.","family":"Kraft","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.L.","family":"Osterhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.N.","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.A.","family":"Garris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2009.03.083_bib1","unstructured":"Abercrombie ED, Russo ML (2002). Neurochemistry in the R6\/2 transgenic mouse model of Huntington's disease. Program number 19512 in Society for Neuroscience 2002, Orlando, FL."},{"key":"10.1016\/j.neuroscience.2009.03.083_bib2","doi-asserted-by":"crossref","first-page":"9585","DOI":"10.1523\/JNEUROSCI.5698-07.2008","article-title":"Decreased striatal dopamine release underlies increased expression of long-term synaptic potentiation at corticostriatal synapses 24 h after 3-nitropropionic-acid-induced chemical hypoxia","volume":"28","author":"Akopian","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib3","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1073\/pnas.74.9.3767","article-title":"3-Nitropropionate, the toxic substance of Indigofera, is a suicide inactivator of succinate dehydrogenase","volume":"74","author":"Alston","year":"1977","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev.ne.16.030193.000445","article-title":"Neurotransmitter transporters: recent progress","volume":"16","author":"Amara","year":"1993","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib5","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1471-4159.1993.tb03633.x","article-title":"Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate","volume":"61","author":"Beal","year":"1993","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib6","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","article-title":"Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid","volume":"13","author":"Beal","year":"1993","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib7","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/j.1471-4159.1991.tb08258.x","article-title":"Aminooxyacetic acid results in excitotoxin lesions by a novel indirect mechanism","volume":"57","author":"Beal","year":"1991","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib8","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1523\/JNEUROSCI.23-12-05020.2003","article-title":"Calpain is a major cell death effector in selective striatal degeneration induced in vivo by 3-nitropropionate: implications for Huntington's disease","volume":"23","author":"Bizat","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib9","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neulet.2003.10.034","article-title":"Chronic intoxication with 3-nitropropionic acid in rats induces the loss of striatal dopamine terminals without affecting nigral cell viability","volume":"354","author":"Blum","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.neulet.2004.07.046","article-title":"Increased Alix (apoptosis-linked gene-2 interacting protein X) immunoreactivity in the degenerating striatum of rats chronically treated by 3-nitropropionic acid","volume":"368","author":"Blum","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib11","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1006\/nbdi.2002.0512","article-title":"Striatal and cortical neurochemical changes induced by chronic metabolic compromise in the 3-nitropropionic model of Huntington's disease","volume":"10","author":"Blum","year":"2002","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib12","doi-asserted-by":"crossref","first-page":"9122","DOI":"10.1523\/JNEUROSCI.22-20-09122.2002","article-title":"The adenosine A1 receptor agonist adenosine amine congener exerts a neuroprotective effect against the development of striatal lesions and motor impairments in the 3-nitropropionic acid model of neurotoxicity","volume":"22","author":"Blum","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib13","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1097\/00001756-200106130-00050","article-title":"Topological analysis of striatal lesions induced by 3-nitropropionic acid in the Lewis rat","volume":"12","author":"Blum","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brainres.2004.01.021","article-title":"Early exploratory behavior abnormalities in R6\/1 Huntington's disease transgenic mice","volume":"1005","author":"Bolivar","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib15","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0301-0082(99)00005-2","article-title":"Replicating Huntington's disease phenotype in experimental animals","volume":"59","author":"Brouillet","year":"1999","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib16","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1073\/pnas.92.15.7105","article-title":"Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates","volume":"92","author":"Brouillet","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib17","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.1471-4159.2005.03515.x","article-title":"3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease","volume":"95","author":"Brouillet","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib18","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1471-4159.1993.tb05859.x","article-title":"Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid","volume":"60","author":"Brouillet","year":"1993","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib19","first-page":"238","article-title":"Inhibition of mitochondrial complex II affects dopamine metabolism and decreases its uptake into striatal synaptosomes","volume":"44","author":"Cakala","year":"2006","journal-title":"Folia Neuropathol"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib20","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1016\/S0021-9258(18)50574-3","article-title":"Inactivation of succinate dehydrogenase by 3-nitropropionate","volume":"254","author":"Coles","year":"1979","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib21","series-title":"The biochemical basis of neuropharmacology","author":"Cooper","year":"2003"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib22","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0896-6273(00)80126-9","article-title":"ATP serves as a negative feedback inhibitor of voltage-gated Ca2+ channel currents in cultured bovine adrenal chromaffin cells","volume":"16","author":"Currie","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib23","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1073\/pnas.88.4.1261","article-title":"Multiple actions of extracellular ATP on calcium currents in cultured bovine chromaffin cells","volume":"88","author":"Diverse-Pierluissi","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib24","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0165-0270(87)90073-2","article-title":"Amino acid neurotransmitters in postmortem human brain analyzed by high performance liquid chromatography with electrochemical detection","volume":"19","author":"Ellison","year":"1987","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib25","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1006\/exnr.2001.7766","article-title":"Perseverative behavior underlying attentional set-shifting deficits in rats chronically treated with the neurotoxin 3-nitropropionic acid","volume":"172","author":"El Massioui","year":"2001","journal-title":"Exp Neurol"},{"issue":"2\u20133","key":"10.1016\/j.neuroscience.2009.03.083_bib26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0014-2999(99)00776-1","article-title":"Striatal dopamine depletion and behavioural sensitization induced by methamphetamine and 3-nitropropionic acid","volume":"386","author":"Eradiri","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib27","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1046\/j.1460-9568.2002.02047.x","article-title":"Dopamine transporter knock-out mice are hypersensitive to 3-nitropropionic acid-induced striatal damage","volume":"15","author":"Fernagut","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-0270(01)00359-4","article-title":"A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor","volume":"107","author":"Fowler","year":"2001","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1113\/jphysiol.1993.sp019847","article-title":"ATP modulation of calcium channels in chromaffin cells","volume":"470","author":"Gandia","year":"1993","journal-title":"J Physiol"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib30","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1523\/JNEUROSCI.14-01-00442.1994","article-title":"Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltammetric study","volume":"14","author":"Garris","year":"1994","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib31","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1471-4159.1992.tb09431.x","article-title":"Quantitative autoradiography of dihydrorotenone binding to complex I of the electron transport chain","volume":"59","author":"Greenamyre","year":"1992","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0306-4522(96)00602-1","article-title":"Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid","volume":"79","author":"Guyot","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib33","series-title":"Huntington's disease","author":"Harper","year":"1991"},{"issue":"1","key":"10.1016\/j.neuroscience.2009.03.083_bib34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/187152706784111605","article-title":"Phasic dopamine signaling during behavior, reward, and disease states","volume":"5","author":"Heien","year":"2006","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1242\/jeb.196.1.251","article-title":"Biochemistry and molecular biology of the vesicular monoamine transporter from chromaffin granules","volume":"196","author":"Henry","year":"1994","journal-title":"J Exp Biol"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib36","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1046\/j.1471-4159.2002.00804.x","article-title":"The role of dopamine in motor symptoms in the R6\/2 transgenic mouse model of Huntington's disease","volume":"81","author":"Hickey","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib37","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1471-4159.2006.03762.x","article-title":"Dopamine release is severely compromised in the R6\/2 mouse model of Huntington's disease","volume":"97","author":"Johnson","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib38","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1111\/j.1471-4159.2007.04908.x","article-title":"Catecholamine exocytosis is diminished in R6\/2 Huntington's disease model mice","volume":"103","author":"Johnson","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib39","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1152\/physrev.1988.68.1.232","article-title":"Accumulation of biological amines into chromaffin granules: a model for hormone and neurotransmitter transport","volume":"68","author":"Johnson","year":"1988","journal-title":"Physiol Rev"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib40","series-title":"Principles of neural science","author":"Kandel","year":"2000"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib41","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1021\/ac00015a017","article-title":"Etched carbon-fiber electrodes as amperometric detectors of catecholamine secretion from isolated biological cells","volume":"63","author":"Kawagoe","year":"1991","journal-title":"Anal Chem"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib42","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/j.1471-4159.2007.05044.x","article-title":"Atorvastatin attenuates mitochondrial toxin-induced striatal degeneration, with decreasing iNOS\/c-Jun levels and activating ERK\/Akt pathways","volume":"104","author":"Lee","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib43","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.brainres.2007.11.058","article-title":"Granulocyte-colony stimulating factor attenuates striatal degeneration with activating survival pathways in 3-nitropropionic acid model of Huntington's disease","volume":"1194","author":"Lee","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib44","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/1096-9861(20001002)425:4<471::AID-CNE1>3.0.CO;2-U","article-title":"Cyclosporin A protects striatal neurons in vitro and in vivo from 3-nitropropionic acid toxicity","volume":"425","author":"Leventhal","year":"2000","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib45","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib46","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0006-2952(02)00910-3","article-title":"Mitochondrial toxin inhibition of [(3)H]dopamine uptake into rat striatal synaptosomes","volume":"63","author":"Maragos","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib47","series-title":"Biochemistry","author":"Mathews","year":"1996"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib48","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0014-4886(03)00044-X","article-title":"Structural and functional neuroprotection in a rat model of Huntington's disease by viral gene transfer of GDNF","volume":"181","author":"McBride","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib49","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/263517a0","article-title":"Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids","volume":"263","author":"McGeer","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib50","doi-asserted-by":"crossref","first-page":"586A","DOI":"10.1021\/ac9819640","article-title":"Color images for fast-scan CV measurements in biological systems","volume":"70","author":"Michael","year":"1998","journal-title":"Anal Chem"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib51","first-page":"155","article-title":"Role of endocrine cell microvesicles in intercellular chemical transduction","volume":"377","author":"Moriyama","year":"1996","journal-title":"Biol Chem Hoppe Seyler"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib52","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF03033979","article-title":"Behavioral alterations in Lewis rats following two-day continuous 3-nitropropionic acid administration","volume":"8","author":"Newcomb","year":"2005","journal-title":"Neurotox Res"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib53","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0306-4522(00)00020-8","article-title":"Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies","volume":"97","author":"Ouary","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib54","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0306-4522(00)00020-8","article-title":"Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies","volume":"97","author":"Ouary","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib55","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neulet.2008.10.020","article-title":"Galantamine reduces striatal degeneration in 3-nitropropionic acid model of Huntington's disease","volume":"448","author":"Park","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib56","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"2005"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib57","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1006\/nbdi.2002.0534","article-title":"Evidence for dysfunction of the nigrostriatal pathway in the R6\/1 line of transgenic Huntington's disease mice","volume":"11","author":"Peters\u00e9n","year":"2002","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib58","series-title":"Numerical recipes in Pascal","author":"Press","year":"1989"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib59","series-title":"Neuromethods: voltammetric methods in brain systems","first-page":"27","article-title":"Diffusion and ion shifts in the brain extracellular microenvironment and their relevance for voltammetric measurements","author":"Rice","year":"1995"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib60","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1006\/exnr.1993.1197","article-title":"Intrastriatal injections of quinolinic acid or kainic acid: differential patterns of cell survival and the effects of data analysis on outcome","volume":"124","author":"Roberts","year":"1993","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib61","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1460-9568.2007.05717.x","article-title":"Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors","volume":"26","author":"Sagredo","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib62","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1152\/physrev.1995.75.2.369","article-title":"Vesicular neurotransmitter transporters: from bacteria to humans","volume":"75","author":"Schuldiner","year":"1995","journal-title":"Physiol Rev"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib63","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/jcbfm.1994.134","article-title":"3-Acetylpyridine produces age-dependent excitotoxic lesions in rat striatum","volume":"14","author":"Schulz","year":"1994","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib64","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1111\/j.1471-4159.1992.tb10080.x","article-title":"1-Methyl-4-phenylpyridinium produces excitotoxic lesions in rat striatum as a result of impairment of oxidative metabolism","volume":"58","author":"Storey","year":"1992","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib65","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.pneurobio.2005.04.003","article-title":"Mechanisms of neurotransmitter release by amphetamines: a review","volume":"75","author":"Sulzer","year":"2005","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib66","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib67","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1523\/JNEUROSCI.0590-05.2005","article-title":"Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease","volume":"25","author":"Van Raamsdonk","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib68","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1471-4159.2003.01527.x","article-title":"Correlation of local changes in extracellular oxygen and pH that accompany dopaminergic terminal activity in the rat caudate-putamen","volume":"84","author":"Venton","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib69","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0306-4522(99)00500-X","article-title":"Dopamine release and uptake are greater in female than male rat striatum as measured by fast cyclic voltammetry","volume":"95","author":"Walker","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib70","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1745-7254.2006.00410.x","article-title":"Animal models of Huntington's disease: implications in uncovering pathogenic mechanisms and developing therapies","volume":"27","author":"Wang","year":"2006","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib71","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0306-4522(88)90255-2","article-title":"Real-time characterization of dopamine overflow and uptake in the rat striatum","volume":"25","author":"Wightman","year":"1988","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2009.03.083_bib72","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0165-0270(01)00459-9","article-title":"Determination of release and uptake parameters from electrically evoked dopamine dynamics measured by real-time voltammetry","volume":"112","author":"Wu","year":"2001","journal-title":"J Neurosci Methods"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452209005417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452209005417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T03:02:05Z","timestamp":1633316525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452209005417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0306452209005417"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2009.03.083","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}